216 related articles for article (PubMed ID: 35834140)
1. c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer.
Wang Z; Huang Y; Lu W; Liu J; Li X; Zhu S; Liu H; Song Y
Med Oncol; 2022 Jul; 39(10):140. PubMed ID: 35834140
[TBL] [Abstract][Full Text] [Related]
2. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
3. DDX5 promotes proliferation and tumorigenesis of non-small-cell lung cancer cells by activating β-catenin signaling pathway.
Wang Z; Luo Z; Zhou L; Li X; Jiang T; Fu E
Cancer Sci; 2015 Oct; 106(10):1303-12. PubMed ID: 26212035
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA circRHOT1 contributes to pathogenesis of non-small cell lung cancer by epigenetically enhancing C-MYC expression through recruiting KAT5.
Ren X; Yu J; Guo L; Ma H
Aging (Albany NY); 2021 Aug; 13(16):20372-20382. PubMed ID: 34406978
[TBL] [Abstract][Full Text] [Related]
5. NAT10 Promotes Malignant Progression of Lung Cancer via the NF-κB Signaling Pathway.
Liu X; Liu X; Zhuo C; Shen J; Lu K; Sha M; Ye J; Huang J; Han H; Yu H
Discov Med; 2023 Dec; 35(179):936-945. PubMed ID: 38058058
[TBL] [Abstract][Full Text] [Related]
6. N-myc downstream regulated gene 1(NDRG1) promotes the stem-like properties of lung cancer cells through stabilized c-Myc.
Wang Y; Zhou Y; Tao F; Chai S; Xu X; Yang Y; Yang Y; Xu H; Wang K
Cancer Lett; 2017 Aug; 401():53-62. PubMed ID: 28456659
[TBL] [Abstract][Full Text] [Related]
7. C-MYC-induced upregulation of LINC01503 promotes progression of non-small cell lung cancer.
Zhang ML; Zhao TT; Du WW; Yang ZF; Peng W; Cui ZJ
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11120-11127. PubMed ID: 33215429
[TBL] [Abstract][Full Text] [Related]
8. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
[TBL] [Abstract][Full Text] [Related]
9. MiR-376a suppresses the proliferation and invasion of non-small-cell lung cancer by targeting c-Myc.
Wang Y; Cong W; Wu G; Ju X; Li Z; Duan X; Wang X; Gao H
Cell Biol Int; 2018 Jan; 42(1):25-33. PubMed ID: 28741879
[TBL] [Abstract][Full Text] [Related]
10. PGE2-driven expression of c-Myc and oncomiR-17-92 contributes to apoptosis resistance in NSCLC.
Krysan K; Kusko R; Grogan T; O'Hearn J; Reckamp KL; Walser TC; Garon EB; Lenburg ME; Sharma S; Spira AE; Elashoff D; Dubinett SM
Mol Cancer Res; 2014 May; 12(5):765-74. PubMed ID: 24469837
[TBL] [Abstract][Full Text] [Related]
11. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc.
Chen Z; Zeng H; Guo Y; Liu P; Pan H; Deng A; Hu J
J Exp Clin Cancer Res; 2010 Nov; 29(1):151. PubMed ID: 21092188
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-184 Deregulated by the MicroRNA-21 Promotes Tumor Malignancy and Poor Outcomes in Non-small Cell Lung Cancer via Targeting CDC25A and c-Myc.
Lin TC; Lin PL; Cheng YW; Wu TC; Chou MC; Chen CY; Lee H
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1532-9. PubMed ID: 25990966
[TBL] [Abstract][Full Text] [Related]
13. C-myc/miR-150/EPG5 axis mediated dysfunction of autophagy promotes development of non-small cell lung cancer.
Li H; Liu J; Cao W; Xiao X; Liang L; Liu-Smith F; Wang W; Liu H; Zhou P; Ouyang R; Yuan Z; Liu J; Ye M; Zhang B
Theranostics; 2019; 9(18):5134-5148. PubMed ID: 31410206
[No Abstract] [Full Text] [Related]
14. Overexpression of Long Non-Coding RNA ZXF2 Promotes Lung Adenocarcinoma Progression Through c-Myc Pathway.
Yang ZT; Li Z; Wang XG; Tan T; Yi F; Zhu H; Zhao JP; Zhou XF
Cell Physiol Biochem; 2015; 35(6):2360-70. PubMed ID: 25896422
[TBL] [Abstract][Full Text] [Related]
15. CircRNA_010763 promotes growth and invasion of lung cancer through serving as a molecular sponge of miR-715 to induce c-Myc expression.
Zhang P; Xue XF; Ling XY; Yang Q; Yu Y; Xiao J; Wang ZN
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7310-7319. PubMed ID: 32706069
[TBL] [Abstract][Full Text] [Related]
16. Candidate tumour suppressor CCDC19 regulates miR-184 direct targeting of C-Myc thereby suppressing cell growth in non-small cell lung cancers.
Liu Z; Mai C; Yang H; Zhen Y; Yu X; Hua S; Wu Q; Jiang Q; Zhang Y; Song X; Fang W
J Cell Mol Med; 2014 Aug; 18(8):1667-79. PubMed ID: 24976536
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of MYCN promotes proliferation of non-small cell lung cancer.
Liu K; Wang S; Liu Y; Gu J; Gu S; Xu Z; Zhang R; Wang Z; Ma H; Chen Y; Ji L
Tumour Biol; 2016 Sep; 37(9):12855-12866. PubMed ID: 27449038
[TBL] [Abstract][Full Text] [Related]
18. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
19. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
20. RALY may cause an aggressive biological behavior and a dismal prognosis in non-small-cell lung cancer.
Song G; Guo G; Du T; Li X; Wang J; Yan Y; Zhao Y
Exp Cell Res; 2020 Apr; 389(2):111884. PubMed ID: 32014444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
